Relief Therapeutics Holding AG

11/24/2021 | Press release | Distributed by Public on 11/24/2021 00:04

Relief Reports that its U.S. Collaboration Partner has Announced the U.S. Food and Drug Administration has Denied Breakthrough Designation for Aviptadil